Biohaven Ltd. Proceeds from (Payments for) Other Financing Activities
Biohaven Ltd. (BHVN) reported Proceeds from (Payments for) Other Financing Activities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-10
- Biohaven Ltd. proceeds from (payments for) other financing activities for the quarter ending 2026-06-30 was $0.00.
- Biohaven Ltd. proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was $0.00.
- Biohaven Ltd. proceeds from (payments for) other financing activities for the quarter ending 2025-12-31 was -$194.00K.
- Biohaven Ltd. proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was $0.00.
- Biohaven Ltd. proceeds from (payments for) other financing activities for fiscal 2025 was -$194.00K, a 108.59% decline from fiscal 2024.
- Biohaven Ltd. proceeds from (payments for) other financing activities for fiscal 2024 was $2.26M.
- Biohaven Ltd. proceeds from (payments for) other financing activities for fiscal 2023 was $0.00.
- Biohaven Ltd. proceeds from (payments for) other financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 3 month as first filed | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 12 month | Proceeds from (Payments for) Other Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | -$194.00K derived: sum of 3 quarters · filed 2026-08-10 | -$194.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | -$194.00K derived: sum of 2 quarters · filed 2026-05-04 | -$194.00K derived: sum of 3 quarters · filed 2026-05-04 | -$194.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$194.00K derived: sum of 2 quarters · filed 2026-03-02 | -$194.00K derived: sum of 3 quarters · filed 2026-08-10 | -$194.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $1.04M derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $1.04M derived: sum of 3 quarters · filed 2026-03-02 | $2.26M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.04M derived: sum of 2 quarters · filed 2025-11-10 | $2.26M 10-Q · filed 2025-11-10 | $401.00K derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.26M 10-Q · filed 2025-08-11 | $401.00K derived: sum of 3 quarters · filed 2026-03-02 | $2.26M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-12 | -$637.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.22M derived: sum of 3 quarters · filed 2026-03-02 | $1.22M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.86M derived: sum of 2 quarters · filed 2024-11-12 | $1.86M 10-Q · filed 2024-11-12 | $1.86M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $1.13M 10-Q · filed 2023-07-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $332.00K 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | $451.00K 10-K · filed 2023-03-23 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $0.00 10-Q · filed 2023-07-31 | $0.00 derived: sum of 3 quarters · filed 2023-07-31 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $395.00K 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | $395.00K 10-Q · filed 2022-11-09 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |